Amyotrophic lateral sclerosis (ALS) is a rare neurological disorder that affects specific nerve cells in the spinal cord known as motor neurons. Symptoms involve issues with swallowing and speech ...
Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...
Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...
spinal), site of spinal onset (upper limbs, lower limbs, upper and lower limbs, trunk), delay between symptom onset and diagnosis (DOD, 0–6, 7–12, 13–24 months, ≥25 months), body-mass ...
Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the develo ...
A clinical trial evaluating the drug fosigotifator in patients with amyotrophic lateral sclerosis has failed to meet its primary endpoint, according to topline results from the Healey ALS platform ...
Hosted on MSN6mon
Signs and Symptoms of Amyotrophic Lateral Sclerosis (ALS)Formerly known as Lou Gehrig’s disease, amyotrophic lateral sclerosis is now commonly ... and weaken. Symptoms from ALS start mild, like minor and limited muscle weakness, but they worsen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback